Jubilant Ingrevia commissions new UP facility for Diketene
18 February 2022 | News
The commissioned facility has about 7,000 TPA capacity to produce various esters
Image credit: https://jubilantingrevia.com/
Jubilant Ingrevia has announced the commissioning of its new Diketene derivatives facility at its manufacturing site in North India at Gajraula, Uttar Pradesh.
The newly commissioned facility marks the entry of Jubilant Ingrevia into the fast-growing Diketene business portfolio. This reiterates Jubilant Ingrevia's commitment towards growth through its integrated business model, by providing value-added products and innovative solutions to its customers.
The commissioned facility has about 7,000 TPA capacity to produce various esters (Mono Methyl Acetoacetamide, Methyl Acetoacetate, Ethyl Acetoacetate and Ter-Butyl Acetoacetate). Jubilant Ingrevia undertakes to commission future phases of Diketene Derivatives as per plan.
